Event Cost: $50
2019 ANSA Annual Conference & Workshops: Gateway to Health
The Applied Neuroscience Society of Australasia is a membership organization comprised of health professionals from Australia, Australasia and New Zealand who are involved in the promotion of better mental health. ANSA promotes education and professional excellence in the fields of Applied Psychophysiology, Neurotherapy and Nutrition seeking to strengthen acceptance of these disciplines as viable avenues for intervention to promote self-regulation in mental health and well-being. ANSA members and other professionals interested in applied neuroscience, are cordially invited to participate our annual workshops and conference to be held in Cairns, gateway to the Great Barrier Reef.
Michelle Aniftos, Martijn Arns, Mirjana Askovic, Trevor Brown, Dave Cantor, George Carlson, Dirk de Ridder, Nick Dogris, Georgina Hale, Peggy Hill, Herbert Jelinek, Martha Mack, Paula Rodrigues, Laura Rosas Leong, Rivi Sela, Dave Siever, Ron Swatzyna, Tiff Thompson, Adrian van Deusen, Steven Wickens, and more…
Thursday 22/08/19> Mental Health Neurobiomarkers: discovering neurological/physiological causes for symptoms is key for successful treatment
Friday 23/08/19> Pharmaco-EEG & Neuromodulation
Dr. Ronald J. Swatzyna is the Director of Electro-Neurophysiology Research and Director of Neurotherapy at the Tarnow Center in Houston, Texas. For the past 20 years, Dr. Swatzyna has analyzed and treated the most diagnostically challenging cases in both inpatient and outpatient settings. As a researcher, he has presented and/or published over 60 peer-reviewed papers on brain dysfunction, psychotropic medication and other related topics at national and international conferences. In addition, Dr. Swatzyna is a Special Editor for WebmedCentral and Clinical EEG and Neuroscience. Prior to his career in mental health, Dr. Swatzyna served in both the Vietnam and the first Gulf War. His personal battle, with traumatic brain injury and PTSD, motivated him to become a leading expert in brain dysfunction.
Thursday & Friday 22-23/08/19> Physiology and Clinical Outcomes with Brain Stimulation Technologies: Audio-visual Entrainment (AVE), Cranio-electro Stimulation (CES) & transcranial DC Stimulation (tDCS)
Dave Siever graduated in 1978 as an engineering technologist who initially worked to design TMJ Dysfunction related diagnostic equipment and research facilities. Dave had noted anxiety issues in many patients suffering with TMJ dysfunction, prompting him to study biofeedback, which he applied to the patients and then later, Dave design biofeedback devices. In 1984, Dave designed his first audio-visual entrainment (AVE) device – the “Digital Audio-visual Integration Device,” or DAVID1. Through his company, Mind Alive Inc., Dave has been researching and refining AVE technology, specifically for use in relaxation, boosting academic performance and treating anxiety, depression, PMS, ADD, FMS, SAD, pain, cognitive decline and insomnia. Dave also designs Cranio-Electro Stimulation (CES) products and is a leading provider of transcranial DC stimulation (tDCS) and devices. As a result of Dave’s commitment to research, Mind Alive Inc now owns three patents involving neurotechnology. Dave continues to conduct research, perform a quantitative EEG service and designs new products pertaining to enhanced performance and mental wellness.
- Monday & Tuesday 26-27/08/19> The Absolute Basics: Beginners EEG Recording and QEEG Analysis
Dr. Rivi Sela is the co-founder and CEO of BetterFly Neurofeedback, an innovative cloud-based neurofeedback technology that allows clinicians to treat patients both in the clinic and at the patient’s home. Rivi pioneered the neurofeedback field in Israel and has trained many neurofeedback clinicians. She founded the BrainGames-Israel clinics ten years ago, and treated hundreds of patients suffering from ADHD, epilepsy, autism, anxiety and depression. Under her supervision, the BrainGames clinics have provided diagnostic evaluations, QEEG recordings and analyses and non-drug interventions to patients of all ages, children and adults. Prior to embarking on her neurofeedback career, Rivi served for many years as the Chief Technology Director of the Sheba Hospital, the largest medical centre in Israel, and specialized in developing and implementing clinical technologies, including hardware and software, collaborating with leading companies from around the world.
Michelle Aniftos BCN QEEGD is a Clinical Psychologist and Director of a private mental health practice (Mylne Street Mental Health) in Toowoomba, Queensland. She has been accredited by Australian Health Practitioner Regulation Agency and the Australian Psychological Society’s Clinical College as a Supervisor of provisional and registered psychologists, and clinical registrars. Michelle is past Convener of the Australian Neurofeedback & Psychology Interest Group; President and Fellow of the Applied Neuroscience Society of Australasia; and Chair of the Biofeedback Certification International Alliance – Australia.
Monday & Tuesday 26-27/08/19> The Use of Neurostimulation (tDCS, tACS, tRNS, pEMF) and Clinical Neurotherapy in Clinical Practice
Dr. Nicholas Dogris is a licensed health psychologist and neuroscientist (BCN & QEEGD) at NeuroField Neurotherapy in Santa Barbara, California. He is the neurorehabilitation director at the Florida House Experience in Deerfield Beach, Florida which is a substance abuse and mental health rehabilitation program. He has been in the electroencephalography (EEG) field for 30 years, beginning in 1987 with P300 research at Humboldt State University. Dr. Dogris earned his PhD from the California School of Professional Psychology and holds four advanced degrees. He has worked in the field for 27 years and has experience working with a wide variety of mental health populations including children, adolescents and adults. Dr. Dogris has held positions as the Program Chief of Mono County Mental Health, Orange County Mental Health, Inyo County Mental Health and College Hospital. He is the co-founder and CEO of NeuroField, Inc which he co-founded in 2008. He developed the first, synchronized, neuromodulation and neurofeedback system that utilized normed referenced data and QEEG analysis for the treatment of multiple neurological problems. This system, known as NeuroField, combines pulsed electromagnetic fields (pEMF) and transcranial alternating/direct current stimulation (tDCS/tACS) with EEG neurofeedback so as to optimize the functioning of the human brain. Dr. Dogris has developed over 200 protocols for the NeuroField system and continues to create new innovations for the Florida House Experience patients with a specific emphasis on reducing cravings, reducing symptoms of anxiety and depression and helping to restore normal sleeping patterns. Dr. Dogris conducts research on tDCS, tACS, tRNS, pEMF and neurofeedback based modalities.
Dr. Tiffany Thompson is the CEO of Neurofield Neurotherapy, Inc. She works alongside her husband, Dr. Dogris, as a clinician and educator in the realm of clinically-applied neurostimulation. Dr. Thompson is a board certified neurotherapist, licensed psychotherapist, Quantitative EEG Diplomate, and Registered EEG Technician (a medical credential bestowed by the American Society of Neurodiagnostic Technicians). Dr Thompson has worked in neurology clinics, as well as clinical settings. She holds two Masters degrees (Depth Counseling Psychology; & Communication). She has a PhD in Psychology with a dissertation on the intersection of psychodynamic psychology model of the psyche and electroencephalography. Dr. Thompson has served as the Executive Director of the Western Association of Biofeedback and Neuroscience, and worked as a neurodiagnostician in neurology clinics. Dr. Thompson regularly delivers public and trade organization lectures on Brain Mapping (Quantitative EEGs), Clinical Quantitative EEGs, Brainwaves 101, neurotherapy, and induced meditative states.